跳至主要内容
临床试验/JPRN-UMIN000008331
JPRN-UMIN000008331已完成未知

A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN JAPANESE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA - A COMPARATIVE STUDY ON THE CLINICAL EFFECTS OF SILODOSIN AND NAFTOPIDIL IN JAPANESE PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

Kobe University Graduate School of Medicine, Division of Urology0 个研究点目标入组 200 人开始时间: 2012年7月3日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 80years-old(—)
性别
Male

入选标准

  • 未提供

排除标准

  • 1) Patients are having the disease other than a benign prostatic hyperplasia (prostate cancer, bladder tumors, bladder stones, prostatitis, bladder neck sclerosis, patients, etc.) 2) Patients have received TUR-P, balloon dilation, urethral stent, hyperthermia, or radiation therapy to the pelvis, within 6 months of the start of the study 3) Self-catheterization 4)Patients with urinary tract infection 5) Patients with concomitant disease and other nervous system diseases, and it suspected to be neurogenic bladder 6) Patients with concomitant severe ischemic heart disease, cerebrovascular disease, liver dysfunction, renal dysfunction. 7) Patients with hypotension 8) Patients are having hypersensitivity to silodosin, naftopidil or taking vardenafil hydrochloride 9) Patients have treated with hormonal drug within 6 months 10) Patients treated with drugs other than tamsulosin is considered effective on urinary symptoms within a week 11) Patients was deemed by the physician as inappropriate to attend

研究者

发起方
Kobe University Graduate School of Medicine, Division of Urology

相似试验